| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |